Skip to main content
Clinical Trials/JPRN-UMIN000000998
JPRN-UMIN000000998Completed未知

Primary Hyperaldosteronism in Japan - PHAS-J

ational Hospital Organization0 sites3,500 target enrollmentStarted: February 1, 2008Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
3,500

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
20years-old to 75years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1)pregnant patients 2)patients taking diuretics or aldosterone antagonist 3)patients with the following diseases: (1)secondary hypertension (renal hypertension,renovascular hypertension, primary aldosteronism, Cushing's syndrome, pheochromocytoma, iatrogenic diseases etc) (2)patients whom the attending doctors decides not suitable for the entry because of the unstable stage of the following complications: coronary diseases, arrhythmia, severe valvular diseases, cerebrovascular diseases, acute and chronic renal failure (serum Cr higher than 3mg/dl), acute and chronic liver diseases (3)orthostatic hypotension 4) Patients whom the attending doctor decides not suitable for the entry of the study.

Investigators

Sponsor
ational Hospital Organization

Similar Trials